Sino Biopharmaceutical Limited has entered into a global strategic collaboration with Schrödinger Inc. to advance the discovery and development of innovative drugs. This partnership will focus on addressing unmet clinical needs, with Schrödinger eligible for milestone payments and tiered royalties based on the success of the collaborative projects. The agreement aims to leverage both companies' expertise in drug discovery and development. AI
IMPACT This partnership leverages AI in drug discovery, potentially accelerating the development of new treatments.
RANK_REASON Partnership between two companies for drug discovery.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
